Argitalpenak (10) Ikertzaileren baten partaidetza izan duten argitalpenak

2001

  1. Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes

    Journal of Hepatology, Vol. 34, Núm. 2, pp. 321-329

  2. Dendritic cells infected with recombinant defective adenoviruses undergo NF-kB activation and partial maturation

    INMUNOLOGÍA, Vol. 20, Núm. 3, pp. 130-142

  3. Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12

    Hepatology, Vol. 33, Núm. 1, pp. 52-61

  4. Gene therapy of primary and metastatic liver tumors.

    Medical science monitor : international medical journal of experimental and clinical research, Vol. 7 Suppl 1, pp. 76-77

  5. Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12

    Gene Therapy, Vol. 8, Núm. 4, pp. 259-267

  6. IL-12 gene therapy for cancer: In synergy with other immunotherapies

    Trends in Immunology, Vol. 22, Núm. 3, pp. 113-115

  7. Identification of the B-cell tumor-specific molecular fingerprint using non-radiolabelled PCR consensus primers

    Annals of Oncology, Vol. 12, Núm. 10, pp. 1479-1484

  8. Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity

    European Journal of Immunology, Vol. 31, Núm. 6, pp. 1780-1789

  9. Thrombopenic purpura induced by a monoclonal antibody directed to a 35-kilodalton surface protein (p35) expressed on murine platelets and endothelial cells

    Experimental Hematology, Vol. 29, Núm. 5, pp. 589-595

  10. αvβ3 Integrin-mediated adenoviral transfer of interleukin-12 at the periphery of hepatic colon cancer metastases induces VCAM-1 expression and T-cell recruitment

    Molecular Therapy, Vol. 3, Núm. 5, pp. 665-672